Abstract:
This invention relates to mouse and human EGFH2, and to variants thereof and to polynucleotides encoding EGFH2. This invention also relates to therapeutic agents related to the polynucleotides and proteins.
Abstract:
This invention relates to mouse and human EGFH2, and to variants thereof and to polynucleotides encoding EGFH2. This invention also relates to therapeutic agents related to the polynucleotides and proteins.
Abstract:
This invention relates to mouse and human EGFH2, and to variants thereof and to polynucleotides encoding EGFH2. This invention also relates to therapeutic agents related to the polynucleotides and proteins.
Abstract:
This invention relates to mouse and human EGFH2, and to variants thereof and to polynucleotides encoding EGFH2. This invention also relates to therapeutic agents related to the polynucleotides and proteins.
Abstract:
This invention relates to mouse and human EGFH2, and to variants thereof and to polynucleotides encoding EGFH2. This invention also relates to therapeutic agents related to the polynucleotides and proteins.
Abstract:
A method and apparatus for providing useful packet data to a CALEA/Legal Intercept collection function. At an access point to a network such as the Internet, sources and destinations of data connections are examined to determine whether any of the bearer messages should also be routed to a CALEA/Legal Intercept monitoring system. If this condition is recognized, the bearer messages and corresponding signaling control messages are correlated in a call packet delivery application server and then delivered to a CALEA/Legal Intercept monitoring system. Advantageously, the monitoring receives as a bundled message set the bearer message and the control messages used to route and otherwise process these bearer messages.